Tasly Pharmaceutical Group Co., Ltd.
USPTO PatentsView assignee record - 30 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Tasly ranks #10,472 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 10 technology areas.
- #10,472
- of 49,997 US assignees by volume
- 49th percentile
- by Innovation Score (35.0/100)
- 15.3
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10472 · Foreign Corporation #10,472 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,472/49,997
- PHOTO-FINISH Stetrix
- CPC-FOCUS A61P · 10 areas
- INNOV-THIN 35.0/100
- CLAIMS-RICH 15.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Stetrix, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Tasly’s 35.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Tasly
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Caroma Industries · near
Caroma Industries · near
35 score
- Colebrook Bosson &… · near
Colebrook Bosson &… · near
35 score
- Elira · near
Elira · near
35 score
- Tasly Pharmaceutical… · this assignee
Tasly Pharmaceutical… · this assignee
35 score
- TBS Engineering · near
TBS Engineering · near
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Tasly's Innovation Score is 35.0/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Tasly?
Each dot is one of Tasly’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tasly’s own 15.3 claims/patent is ABOVE the 12.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Tasly's grants concentrate
Tasly Pharmaceutical Group Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 86.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2017. By volume, Tasly sits between Stetrix, Inc. and Thule Organization Solutions, Inc..
Tasly's three-year grant acceleration
Tasly Pharmaceutical Group Co., Ltd. shows 5 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Tasly's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Stetrix
Stetrix, Inc.
30 patents
- Sunjoy Industries…
Sunjoy Industries Group Ltd.
30 patents
- Surgiquest
Surgiquest, Inc.
30 patents
- Syneurx Internati…
SyneuRx International (Taiwan) Corp.
30 patents
- Tecomec S R L
Tecomec S.R.L.
30 patents
- Teledyne Lecroy
Teledyne Lecroy, Inc.
30 patents
- THE Secant Group
THE Secant Group, LLC
30 patents
- Thule Organizatio…
Thule Organization Solutions, Inc.
30 patents
- Tasly Pharmaceuti… ◀
Tasly Pharmaceutical Group Co., Ltd.
30 patents
What this shows Tasly holds 30 patents at rank #10,471, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Tasly
By rank, the assignees closest to #10,471 in granted patent volume.
- Stetrix, Inc. #10,467 · 30 patents
- Sunjoy Industries Group Ltd. #10,468 · 30 patents
- Surgiquest, Inc. #10,469 · 30 patents
- SyneuRx International (Taiwan) Corp. #10,470 · 30 patents
- Tecomec S.R.L. #10,472 · 30 patents
- Teledyne Lecroy, Inc. #10,473 · 30 patents
- THE Secant Group, LLC #10,474 · 30 patents
- Thule Organization Solutions, Inc. #10,475 · 30 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Tasly's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Tasly, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Tasly ranks #760 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (35 here).
Tasly's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 49th percentile higher than 49% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 20.0% |
| 2017 | 1 | 3.3% |
| 2018 | 6 | 20.0% |
| 2019 | 7 | 23.3% |
| 2020 | 3 | 10.0% |
| 2021 | 2 | 6.7% |
| 2022 | 4 | 13.3% |
| 2024 | 1 | 3.3% |
Which technologies does Tasly Pharmaceutical Group Co., Ltd. patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Tasly Pharmaceutical Group Co., Ltd.'s patent record in context - here's where to go next.
- Tasly Pharmaceutical Group Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 86.7% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #10,472 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Tasly Pharmaceutical Group Co., Ltd. against Stetrix, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.